Stryker Corporation vs Vertex Pharmaceuticals Incorporated
Market cap comparison over time
Stryker Corporation
$133.5B
Rank #128
Vertex Pharmaceuticals Incorporated
$134.2B
Rank #126
Market Cap Over Time
Key Moments
- Stryker Corporation overtook Vertex Pharmaceuticals Incorporated by 1998
- Vertex Pharmaceuticals Incorporated overtook Stryker Corporation by 2000
- Stryker Corporation overtook Vertex Pharmaceuticals Incorporated by 2001
- Vertex Pharmaceuticals Incorporated overtook Stryker Corporation by 2015
- Stryker Corporation overtook Vertex Pharmaceuticals Incorporated by 2016
- Vertex Pharmaceuticals Incorporated overtook Stryker Corporation by 2026
Year-by-Year Comparison
| Year | Stryker Corporation | Vertex Pharmaceuticals Incorporated | Leader |
|---|---|---|---|
| 2026 | $133.5B | $134.2B | Vertex Pharmaceuticals Incorporated |
| 2025 | $134.0B | $115.1B | Stryker Corporation |
| 2024 | $136.1B | $102.2B | Stryker Corporation |
| 2023 | $112.1B | $103.3B | Stryker Corporation |
| 2022 | $90.5B | $73.3B | Stryker Corporation |
| 2021 | $97.8B | $55.7B | Stryker Corporation |
| 2020 | $88.7B | $60.0B | Stryker Corporation |
| 2019 | $75.1B | $55.6B | Stryker Corporation |
| 2018 | $55.5B | $42.1B | Stryker Corporation |
| 2017 | $54.2B | $38.0B | Stryker Corporation |
| 2016 | $41.4B | $18.7B | Stryker Corporation |
| 2015 | $31.6B | $31.9B | Vertex Pharmaceuticals Incorporated |
| 2014 | $31.6B | $30.2B | Stryker Corporation |
| 2013 | $24.8B | $18.9B | Stryker Corporation |
| 2012 | $17.8B | $10.6B | Stryker Corporation |
| 2011 | $15.9B | $8.4B | Stryker Corporation |
| 2010 | $16.9B | $8.9B | Stryker Corporation |
| 2009 | $15.7B | $10.9B | Stryker Corporation |
| 2008 | $12.3B | $7.7B | Stryker Corporation |
| 2007 | $22.9B | $5.9B | Stryker Corporation |
| 2006 | $16.8B | $9.5B | Stryker Corporation |
| 2005 | $13.5B | $7.0B | Stryker Corporation |
| 2004 | $14.7B | $2.7B | Stryker Corporation |
| 2003 | $12.9B | $2.6B | Stryker Corporation |
| 2002 | $10.2B | $4.0B | Stryker Corporation |
| 2001 | $8.8B | $6.2B | Stryker Corporation |
| 2000 | $7.6B | $18.1B | Vertex Pharmaceuticals Incorporated |
| 1999 | $5.3B | $4.4B | Stryker Corporation |
| 1998 | $4.2B | $3.8B | Stryker Corporation |
| 1997 | $2.8B | $4.2B | Vertex Pharmaceuticals Incorporated |
| 1996 | $2.2B | $5.1B | Vertex Pharmaceuticals Incorporated |
| 1995 | $2.0B | $3.4B | Vertex Pharmaceuticals Incorporated |
| 1994 | $1.4B | $1.9B | Vertex Pharmaceuticals Incorporated |